Author: Alan Brochstein, CFA

[ad_1] Cannabis stocks began the year with a bounce that ended quickly with an all-time low set in June for the Global Cannabis Stock Index , but July was strong. The index rallied 13.1% to 8.48: The end of 2022 was challenging, with the index falling 23.7% in Q3 and 13.8% in Q4, which contributed to a 70.4% decline for the full year.  In 2023, Q1 saw a 12.5% decline, and the index, which dropped 11.8% in Q2, is now down 12.7% year-to-date: Since the peak in February 2021, the Global Cannabis Stock Index has dropped 90.8% from the 92.48 closing high, dropping…

[ad_1] You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, It’s almost month-end, and we will publish a review of the indices during July next week. The market, as measured by the New Cannabis Ventures Global Cannabis Stock Index, is still under pressure, down 16.5% so far in 2023, but it has rallied so far during the month. The index has…

[ad_1] The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis companies. Most of the companies will be reporting Q2 in the next few weeks for the quarter that ended 6/30. Tracker Rules This data-driven, fact-based tracker will continually update based on new financial filings so that readers can stay up to date. Companies must file with the SEC or SEDAR and be current to be considered for inclusion. When we launched this resource in May 2019, companies with quarterly revenue in excess of US$2.5 million qualified. As the industry has scaled…

[ad_1] You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, Cannabis stocks plunged when stocks overall were enjoying a large rally, and they fell this past week when they fell. Year-to-date, the New Cannabis Ventures Global Cannabis Stock Index has dropped 19.0%, while the S&P 500 has soared by 18.2%. We are not expecting any sort of “opposite effect” if stocks…

[ad_1] Statistics Canada released May retail sales for the country, with cannabis sales rising from the April levels, up 1.2% to C$415.6 million. April was revised slightly lower to C$410.6 million. The sales, which fell 2.1% on a per-day basis, were up 11.2% from a year ago, up from the 10.0% April growth rate. In 2022, total sales increased 17.9% to C$4.52 billion, and they have increased 12.1% thus far in 2023. An increase in the number of stores as well as falling flower prices that bring consumers from the illicit market have been boosting sales. In Ontario, the largest province in…

[ad_1] You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, On July 5th, an analyst changed his target on Canopy Growth to zero from C$1.75. The stock was trading then at C$0.73. Despite the aggressive target after such a big decline, the stock still fell further and continues to do so, posting a new all-time low on Friday. Our readers didn’t…

[ad_1] July 14, 2023 at 11:42 am Michigan cannabis sales rose 6.0% in June from the longer May to a record $260.8 million. On a per-day basis, sales grew 8.8%. The growth of 39.2% from a year ago was up from the 31.9% level last month: The Michigan Cannabis Regulatory Agency breaks out sales by medical and adult-use, with medical sales falling 69.1% from a year ago to $6.6 million, down 5.8% sequentially, and adult-use sales expanding 53.2% year-over-year to $254.2 million, up 6.4% sequentially: The state breaks out sales by category and provides pricing detail by category, for both medical and…

[ad_1] You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, This past week, one of our favorite cannabis stocks, Organigram (NASDAQ: OGI) (TSX: OGI), reverse-split its stock in order to maintain its NASDAQ listing. We have written about it here several times, most recently in mid-June when we suggested it is a much smarter option for cannabis investors than Canopy Growth. …

[ad_1] Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in…

[ad_1] New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states. Cannabis sales decreased 0.5% sequentially in May after decreasing 3.6% in April, according to cannabis data analytics firm BDSA. Looking at a per-day basis, sales decreased 3.7% sequentially. In this review, we share the results by state, beginning with the eastern markets and then concluding with the western markets. In total, BDSA estimates that sales across the 11 markets totaled $1.71 billion during the month. Eastern Markets BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan and Pennsylvania. In May, year-over-year…

[ad_1] You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, A year ago, the low cannabis stock prices captured our attention, and we really liked cannabis stocks. This year, though, we have been a lot smarter and have been warning readers regularly about the challenges the stocks face. We just completed a quarter, and the New Cannabis Ventures Global Cannabis Stock…

[ad_1] As we described in a previous article, the Global Cannabis Stock Index fell again in June, the fifth consecutive monthly decline after a rally to begin the year. That index is now down  down 22.8% year-to-date, which has followed a record decline of 70.4% for 2022. In this article, we will summarize the performance of the other managed indices that New Cannabis Ventures offers to its readers. We will discuss the performance of the American Cannabis Operator Index, Ancillary Cannabis Index and Canadian Cannabis LP Index. Two of the three fell, while one rallied during the month. American Cannabis Stocks Index The American Cannabis…